128 related articles for article (PubMed ID: 38351310)
41. Clinical Characteristics and Short-Term Outcomes of Children With Asparaginase-Associated Pancreatitis.
Mauney EE; Power-Hays A; Flamand Y; Vrooman L; Silverman LB; Grover AS
J Pediatr Gastroenterol Nutr; 2022 Mar; 74(3):402-407. PubMed ID: 34694268
[TBL] [Abstract][Full Text] [Related]
42. Pancreatic panniculitis caused by L-asparaginase induced acute pancreatitis in a child with acute lymphoblastic leukemia.
Chiewchengchol D; Wananukul S; Noppakun N
Pediatr Dermatol; 2009; 26(1):47-9. PubMed ID: 19250405
[TBL] [Abstract][Full Text] [Related]
43. Allogeneic bone marrow transplantation after L-asparaginase-induced pancreatitis in a patient with acute lymphoblastic leukemia.
Yamada Y; Ito K; Watanabe Y; Nosaka K; Horikawa K; Hidaka M; Kawano F; Sasaki Y; Mitsuya H; Asou N
Leuk Res; 2008 Dec; 32(12):1944-6. PubMed ID: 18502503
[No Abstract] [Full Text] [Related]
44. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
[TBL] [Abstract][Full Text] [Related]
45. Surgical pancreatic complications induced by L-asparaginase.
Sadoff J; Hwang S; Rosenfeld D; Ettinger L; Spigland N
J Pediatr Surg; 1997 Jun; 32(6):860-3. PubMed ID: 9200086
[TBL] [Abstract][Full Text] [Related]
46. Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia.
Parsons SK; Skapek SX; Neufeld EJ; Kuhlman C; Young ML; Donnelly M; Brunzell JD; Otvos JD; Sallan SE; Rifai N
Blood; 1997 Mar; 89(6):1886-95. PubMed ID: 9058708
[TBL] [Abstract][Full Text] [Related]
47. Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia
.
Thu Huynh V; Bergeron S
Clin J Oncol Nurs; 2017 Oct; 21(5):E248-E259. PubMed ID: 28945721
[TBL] [Abstract][Full Text] [Related]
48. [Successful readministration of L-asparaginase after development of severe hypertriglyceridemia in a young adult with T-cell acute lymphoblastic leukemia].
Watanabe K; Yoshifuji K; Ohkawa R; Tozuka M; Miura O; Arai A
Rinsho Ketsueki; 2018; 59(12):2555-2560. PubMed ID: 30626788
[TBL] [Abstract][Full Text] [Related]
49. [Acute pancreatitis during chemotherapy of acute lymphoblastic leukaemia complicated with pseudocyst].
Sikorska-Fic B; Stańczak E; Matysiak M; Kamiński A
Med Wieku Rozwoj; 2008; 12(4 Pt 2):1051-5. PubMed ID: 19531825
[TBL] [Abstract][Full Text] [Related]
50. Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites.
Toksvang LN; De Pietri S; Nielsen SN; Nersting J; Albertsen BK; Wehner PS; Rosthøj S; Lähteenmäki PM; Nilsson D; Nystad TA; Grell K; Frandsen TL; Schmiegelow K
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28423235
[TBL] [Abstract][Full Text] [Related]
51. Conservative management of pancreatic pseudocysts in children with acute lymphoblastic leukemia.
Spraker HL; Spyridis GP; Pui CH; Howard SC
J Pediatr Hematol Oncol; 2009 Dec; 31(12):957-9. PubMed ID: 19956023
[TBL] [Abstract][Full Text] [Related]
52. TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial.
Klaassen ILM; Lauw MN; van de Wetering MD; Biemond BJ; Middeldorp S; Abbink FCH; Bierings M; Te Loo DMMW; Pieters R; van der Sluis IM; Tissing WJE; Michel Zwaan C; Heleen van Ommen C
BMC Pediatr; 2017 May; 17(1):122. PubMed ID: 28486976
[TBL] [Abstract][Full Text] [Related]
53. Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial.
Vora A; Goulden N; Mitchell C; Hancock J; Hough R; Rowntree C; Moorman AV; Wade R
Lancet Oncol; 2014 Jul; 15(8):809-18. PubMed ID: 24924991
[TBL] [Abstract][Full Text] [Related]
54. Obesity as a predictor of treatment-related toxicity in children with acute lymphoblastic leukaemia.
Egnell C; Heyman M; Jónsson ÓG; Raja RA; Niinimäki R; Albertsen BK; Schmiegelow K; Stabell N; Vaitkeviciene G; Lepik K; Harila-Saari A; Ranta S
Br J Haematol; 2022 Mar; 196(5):1239-1247. PubMed ID: 34726257
[TBL] [Abstract][Full Text] [Related]
55. Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study.
Zhang YY; Yang QS; Qing X; Li BR; Qian J; Wang Y; Ning BT
Front Oncol; 2020; 10():538779. PubMed ID: 33194600
[TBL] [Abstract][Full Text] [Related]
56. Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemia.
Gottschalk Højfeldt S; Grell K; Abrahamsson J; Lund B; Vettenranta K; Jónsson ÓG; Frandsen TL; Wolthers BO; Marquart HV; Vaitkeviciene G; Lepik K; Heyman M; Schmiegelow K; Albertsen BK
Blood; 2021 Apr; 137(17):2373-2382. PubMed ID: 33150360
[TBL] [Abstract][Full Text] [Related]
57. Insufficient secretion of pancreatic FGF21 is the toxicological mechanism and therapeutic target of asparaginase-associated pancreatitis.
He J; Chen Y; Zhong W; Jun L; Chen D; Cheng H; Mei W
Toxicol Appl Pharmacol; 2024 Apr; 485():116920. PubMed ID: 38582373
[TBL] [Abstract][Full Text] [Related]
58. Incidence and outcome of pancreatitis in children and young adults with acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003.
Samarasinghe S; Dhir S; Slack J; Iyer P; Wade R; Clack R; Vora A; Goulden N
Br J Haematol; 2013 Sep; 162(5):710-3. PubMed ID: 23750892
[No Abstract] [Full Text] [Related]
59. Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study.
Tuckuviene R; Ranta S; Albertsen BK; Andersson NG; Bendtsen MD; Frisk T; Gunnes MW; Helgestad J; Heyman MM; Jonsson OG; Mäkipernaa A; Pruunsild K; Tedgård U; Trakymiene SS; Ruud E
J Thromb Haemost; 2016 Mar; 14(3):485-94. PubMed ID: 26707629
[TBL] [Abstract][Full Text] [Related]
60. Concurrent diabetic ketoacidosis and pancreatitis in Paediatric acute lymphoblastic leukemia receiving L-asparaginase.
Jameel PZ; Lohiya S; Dongre A; Damke S; Lakhkar BB
BMC Pediatr; 2020 May; 20(1):228. PubMed ID: 32423425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
